c-LEcta announces the signing of an amendment of a framework supply agreement with one of the world’s TOP 10 pharma companies. It expands the long lasting relation between the companies by the supply of 4 additional enzyme products developed and produced by c-LEcta within the supply agreement.
Especially the pharmaceutical industry with its high quality standards nowadays is one of the main pillars of c-LEcta’s business providing high quality products to regulated markets.
Hence, the current execution of the contract is an important milestone in the very successful 10 year old cooperation of c-LEcta with this undisclosed pharma company.